Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioMark Diagnostics (TSE:BUX)
:BUX
Holding TSE:BUX?
Track your performance easily
BUX Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.18 - C$0.32
Previous CloseN/A
Volume0.00
Average Volume (3M)2.61K
Market Cap
C$18.18M
Enterprise ValueC$23.32M
Total Cash (Recent Filing)$17.49K
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.49
Next Earnings
Mar 04, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding90,886,230
10 Day Avg. Volume0
30 Day Avg. Volume2,613
Standard Deviation0.24
R-Squared0.00500
Alpha0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)112.35
Price to Cash Flow (P/CF)-14.20
P/FCF Ratio0.00
Enterprise Value/Market Cap1.28
Enterprise Value/Revenue147.60
Enterprise Value/Gross Profit142.89
Enterprise Value/Ebitda-15.09
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
BioMark Diagnostics News
PremiumCompany Announcements
BioMark’s Breakthrough in Breast Cancer Diagnosis
PremiumCompany Announcements
BioMark Advances in Breast Cancer Detection Technology
PremiumCompany Announcements
BioMark Advances Cancer Detection with Biomarker Study
PremiumCompany Announcements
BioMark Diagnostics Advances Lung Cancer DetectionPremiumCompany Announcements
BioMark Diagnostics Unveils Cancer Detection Tech at Global Conference
PremiumCompany Announcements
BioMark Diagnostics Secures Key Patent in Cancer Diagnostics
PremiumCompany Announcements
BioMark Diagnostics Highlights Glioblastoma ResearchPremiumCompany Announcements
BioMark Diagnostics Strategizes with Warrants and OptionsOptions Prices
Currently, No data available
---
Ownership Overview
BUX FAQ
What was BioMark Diagnostics’s price range in the past 12 months?
BioMark Diagnostics lowest stock price was C$0.18 and its highest was C$0.32 in the past 12 months.
What is BioMark Diagnostics’s market cap?
BioMark Diagnostics’s market cap is C$18.18M.
When is BioMark Diagnostics’s upcoming earnings report date?
BioMark Diagnostics’s upcoming earnings report date is Mar 04, 2025 which is in 48 days.
How were BioMark Diagnostics’s earnings last quarter?
BioMark Diagnostics released its earnings results on Nov 29, 2024. The company reported -C$0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.006.
Is BioMark Diagnostics overvalued?
According to Wall Street analysts BioMark Diagnostics’s price is currently Overvalued.
Does BioMark Diagnostics pay dividends?
BioMark Diagnostics does not currently pay dividends.
What is BioMark Diagnostics’s EPS estimate?
BioMark Diagnostics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BioMark Diagnostics have?
BioMark Diagnostics has 90,886,230 shares outstanding.
What happened to BioMark Diagnostics’s price movement after its last earnings report?
BioMark Diagnostics reported an EPS of -C$0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of BioMark Diagnostics?
Currently, no hedge funds are holding shares in TSE:BUX
---
Company Description
BioMark Diagnostics
Biomark Diagnostics Inc is a Canada based oncology-focused company. It is engaged in the development of advanced-stage cancer diagnostic business. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor, and assess early treatment for cancer. Its research and development are focused on the role that metabolomics plays in early cancer detection.
---
Technical Analysis
Revive Therapeutics
―
Sernova
―
Reliq Health Technologies
―
DMG Blockchain Solutions
―
---